UnitedHealth Group, now a $297 billion market-cap healthcare leader, finished the last fiscal year with over $75 billion in combined cash, cash equivalents and marketable securities. The company has increased its annual dividend for 16 consecutive years, achieving a 10-year dividend growth rate of 19.3%. Revenue growth of 12.2% year-over-year in the latest quarter drove net income margins above 4%, while return on equity approached 19.3%, underscoring efficient capital deployment across its UnitedHealthcare and Optum platforms.

Beacon Investment Advisory Services slashed its UnitedHealth position by 90.4%, selling 18,239 shares and retaining just 1,938 shares valued at roughly $669,000 by quarter-end. In contrast, Capital Advisors Ltd. LLC boosted its holding by 4.8% to 1,550 shares, HBW Advisory Services added 7.7% for a total of 13,049 shares, and Cohen Klingenstein marginally increased its stake to 17,250 shares. New entrants like Burns Matteson Capital Management committed approximately $2.77 million, while SWS Partners added 290 shares, lifting its position by 7.2%. Overall, institutional investors maintain roughly 87.9% ownership of the company’s equity.